Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...
The Centers for Medicare and Medicaid Services aims to have all Medicare beneficiaries in a value-based arrangement by 2030. But achieving that will be a difficult undertaking, with just 12% of ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...
R syntax can seem a bit quirky, especially if your frame of reference is, well, pretty much any other programming language. Here are some unusual traits of the language you may find useful to ...
Acquisition strengthens Lightbeam's AI-enabled operating system for value-based care by integrating Syntax's innovative incentive modeling platform and adds actuarial services DALLAS, Dec. 4, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results